Preliminary
Book Editors: J.E.O. Rege and Keith Sones
[email protected], [email protected]
Chapter 1: Introduction (J.E.O. Rege & Keith Sones)
[email protected]
The definition and spectrum of ag biotech; the African experience to date; the objectives of the book and how it is organized
Chapter 2: The state of Applications of Agricultural Biotechnology in Sub-Saharan Africa (Dan Kiambi, Joel W. Ochieng' and J.E.O. Rege)
[email protected]
Extent of applications of ag biotech (from low- to high-tech) by sectors (crops, livestock, fisheries, and forestry); differences in applications (within and across sectors) by countries and sub-regions of Africa
Chapter 3: The state of Capacities for Agricultural Biotechnology in Sub-Saharan Africa (J.E.O. Rege, Joel W. Ochieng' and Dan Kiambi)
[email protected]
Including access to complementary technologies (e.g. ICT); others?
Chapter 4: The state of Enabling Environment for Agricultural Biotechnology in Sub-Saharan Africa (J.E.O Rege, Dan Kiambi, and Joel W. Ochieng')
[email protected]
Policy, legislation, investments, links to capacity, IP, etc.
Chapter 5: Impacts of Biotechnology on Sub-Saharan African Agriculture (J.E.O. Rege and Keith Sones)
[email protected]
Qualitative and quantitative outcomes and impacts of ag biotech applications in Africa by sectors (crops, livestock, fisheries, and forestry); Economic (e.g. cost-benefit of these technologies) and social dimensions (e.g. social acceptance?); Are smallholders winning or losing? Win-win possibilities for future
Chapter 6: Gaps and Opportunities for Agricultural Biotechnology in Sub-Saharan Africa (J.E.O. Rege and Keith Sones)
[email protected]
Based on lessons to date, what will it take for Africa to achieve a trajectory of sustained transformative change through use of technologies?
* Mobilizing increased public and private sector investments - incl. IP issues (ref to enabling environment)
* Institutional arrangements for research (e.g. shared facilities across sectors and countries?)
* South-South and South-North collaborations
* Incubation models
*
Cross-border movement of technologies (e.g. quality seed and breeding stock) * Outsource or not? E.g. sequencing/genotyping in China? North America?? Pros and Cons!